Premium
Sentinel lymph node biopsy in patients with ductal carcinoma in situ
Author(s) -
McMasters Kelly M.,
Chao Celia,
Wong Sandra L.,
Martin Robert C. G.,
Edwards Michael J.
Publication year - 2002
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.10641
Subject(s) - medicine , sentinel lymph node , ductal carcinoma , biopsy , axillary lymph node dissection , mastectomy , occult , carcinoma , radiology , lymph node , sentinel node , dissection (medical) , breast cancer , cancer , pathology , alternative medicine
Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with occult invasive tumor the need for axillary lymph node dissection.